How we work

BioGntx invites partners to improve their products

w

Partnerships developement in 4 steps:

01
Our Tech Platform

Understanding our technology platform

02
Prototyping

A re-engineerd substance of your formulation

03
Project Plan

A well defined joint project plan with clear deliverables

04
License Agreement

Leading to a successful partnership cooperation

Bgx 1: IP-Based Technology Platform

Understanding our technology platform.

XXX

Bgx 2: Prototyping of your products

XXX

XXX

Bgx 3: A joint project plan

XXX

XXX 

Bgx 4: License Agreement

XXX

XXX

References

[1] Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70-81. doi:10.1016/S0140-6736(17)31796-8 – https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31796-8/fulltext

[2] Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-836.e2. doi:10.1016/j.cgh.2017.06.037 – https://www.cghjournal.org/article/S1542-3565(17)31352-X/fulltext

[3] Cellier C, Delabesse E, Helmer C, Patey-Mariaud De Serre N, Jabri B, Macintyre E, Cerf-Bensussan N, Brousse N, Colombel JF. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356(9225):203-208. doi:10.1016/S0140-6736(00)02472-4 – https://www.ncbi.nlm.nih.gov/pubmed/10963196

[4] Jabri B, Sollid LM. Mechanisms of Disease: Immunopathogenesis of Celiac Disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3(9):516-525. doi:10.1038/ncpgasthep0608 – https://www.nature.com/articles/ncpgasthep0608

[5] (Source: Genetics Home Reference, a resource from the U.S. National Library of Medicine – https://ghr.nlm.nih.gov/condition/noonan-syndrome#statistics)

[6] (Source: National Organization for Rare Disorders – https://rarediseases.org/rare-diseases/noonan-syndrome/)

[7] (Source: Genetics Home Reference – https://ghr.nlm.nih.gov/condition/noonan-syndrome)

[8] Tekst: Expand-patientorganisation